{"Study":"Lieberman 1998","Treatment1":"Placebo","y1":-1.22,"sd1":3.7,"n1":54,"Treatment2":"Ropinirole","y2":-1.53,"sd2":4.28,"n2":95}
{"Study":"Lieberman 1997","Treatment1":"Placebo","y1":-0.7,"sd1":3.7,"n1":172,"Treatment2":"Pramipexole","y2":-2.4,"sd2":3.4,"n2":173}
{"Study":"Guttman 1997","Treatment1":"Placebo","y1":-0.3,"sd1":4.4,"n1":76,"Treatment2":"Pramipexole","y2":-2.6,"sd2":4.3,"n2":71,"Treatment3":"Bromocriptine","y3":-1.2,"sd3":4.3,"n3":81}
{"Study":"Brunt 2002, Group A","Treatment1":"Ropinirole","y1":-0.24,"sd1":3,"n1":128,"Treatment2":"Bromocriptine","y2":-0.59,"sd2":3,"n2":72}
{"Study":"Brunt 2002, Group B","Treatment1":"Ropinirole","y1":-0.73,"sd1":3,"n1":80,"Treatment2":"Bromocriptine","y2":-0.18,"sd2":3,"n2":46}
{"Study":"Gershanik 1994b","Treatment1":"Bromocriptine","y1":-2.2,"sd1":2.31,"n1":137,"Treatment2":"Cabergoline","y2":-2.5,"sd2":2.18,"n2":131}
{"Study":"Gershanik 1994a","Treatment1":"Bromocriptine","y1":-1.8,"sd1":2.48,"n1":154,"Treatment2":"Cabergoline","y2":-2.1,"sd2":2.99,"n2":143}